Blavatnik Institute RSS Feed

Harvard Medical School has announced 10 recipients of the Blavatnik Institute Early Career Investigator Awards. Totaling $5 million, these grants are designed to fuel high-potential research conducted by some of the most exceptional junior faculty members — those within the first decade of their careers as principal investigators — on the HMS Quadrangle. Get more HMS news The awards were made possible by ongoing support from the Blavatnik Family Foundation that aims to spur scientific advancement and transform those discoveries into new therapies and new tools to diagnose, prevent, and treat…

The next time you pick up a prescription drug, consider this: Its development likely was rooted in academic research. University labs play a vital role in advancing drug discovery and pharmaceutical innovation. Although these discoveries provide new solutions to medical challenges, improve patient outcomes, and promote economic growth, advancing them from the lab into clinical practice remains a major challenge. Get more HMS news Since 2013, the Blavatnik Biomedical Accelerator (BBA) at Harvard University has addressed this challenge by providing funding that supports the progression of…

Work described in this story was made possible in part by federal funding supported by taxpayers. At Harvard Medical School, the future of efforts like this — done in service to humanity — now hangs in the balance due to the government’s decision to terminate large numbers of federally funded grants and contracts across Harvard University. When the lungs are attacked by a virus, the damage doesn’t stop there. The body’s natural defenses cause inflammation while fighting the virus, often leaving lasting problems. Studying mice and lung organoids, a team of Harvard Medical School researchers has…

During his Class Day remarks earlier this year, Harvard Medical School Dean George Q. Daley made a promise to the newly minted MDs and DMDs gathered on the HMS Quad: “Harvard Medical School will always seek the truth, veritas — it is our motto.” Now, the School is underscoring that commitment in both words and bricks and mortar. In recognition of new philanthropic support for its highest priorities, HMS is renaming the New Research Building (NRB) as the Veritas Science Center (VSC). Get more HMS news “I’m enormously grateful for the opportunity to infuse our scientific community with essential…

Work described in this story was made possible in part by federal funding supported by taxpayers. At Harvard Medical School, the future of efforts like this — done in service to humanity — now hangs in the balance due to the government’s decision to terminate large numbers of federally funded grants and contracts across Harvard University. Artificial intelligence-designed proteins may be able to boost production of immune cells, particularly T cells that fight cancer and harmful infections, according to new research out of Harvard Medical School and Boston Children’s Hospital. The work…

Work described in this story was made possible in part by federal funding supported by taxpayers. At Harvard Medical School, the future of efforts like this — done in service to humanity — now hangs in the balance due to the government’s decision to terminate large numbers of federally funded grants and contracts across Harvard University. A group of nerve cells known for their role in detecting chemical irritation, tissue damage, heat, and pressure now emerge as critical defenders against the worst ravages of the flu caused by an overactive immune response, according to new research by…

Work described in this story was made possible in part by federal funding supported by taxpayers. At Harvard Medical School, the future of efforts like this — done in service to humanity — now hangs in the balance due to the government’s decision to terminate large numbers of federally funded grants and contracts across Harvard University. In a discovery that could expand the array of current cancer immunotherapy treatments, scientists at Harvard Medical School have identified a new molecular brake that hinders the ability of T cells to attack tumors. The research, published Aug. 12 in Nature…

Work described in this story was made possible in part by federal funding supported by taxpayers. At Harvard Medical School, the future of efforts like this — done in service to humanity — now hangs in the balance due to the government’s decision to terminate large numbers of federally funded grants and contracts across Harvard University. What is the earliest spark that ignites the memory-robbing march of Alzheimer’s disease? Why do some people with Alzheimer’s-like changes in the brain never go on to develop dementia? These questions have bedeviled neuroscientists for decades. Now, a team of…